Home | Research & Innovation | Scientific Programmes | Biobank

Research Scientists

  • Nuria Ajenjo
  • María Jesús Artiga


  • Daniel Alba
  • Inmaculada Almenara
  • María del Pilar Caro
  • José Miguel Escolano
  • Sergio Fernández
  • Elena Milagrosa Molina
  • Cecilia Sobrino

The main goal of CNIO Biobank is to facilitate access to quality human samples and their associated data for research in cancer and related diseases, ensuring that both the acquisition and their use comply with all the legal and ethical principles that safeguard donors’ rights.

CNIO Biobank is a cross-service platform for CNIO researchers and the general scientific community that offers broad service covering all stages in research project management requiring the use of human samples. CNIO Biobank offers: sample processing; collection management; quality, ethical and legal consultancy; acquisition and design of valuable research collections; negotiation with different stakeholders to find suitable samples; and/or help to obtain the ethical approval for research projects.

CNIO Biobank is authorised by the Consejería de Sanidad de la Comunidad Autónoma de Madrid (CAM) and registered in the Registro Nacional de Biobancos del Instituto de Salud Carlos III (ID: B. 848).


    SELECT dxsjj_posts.* FROM dxsjj_posts LEFT JOIN dxsjj_postmeta ON ( dxsjj_posts.ID = dxsjj_postmeta.post_id ) LEFT JOIN dxsjj_postmeta AS mt1 ON ( dxsjj_posts.ID = mt1.post_id AND mt1.meta_key = 'factor_impacto' ) LEFT JOIN dxsjj_postmeta AS mt2 ON ( dxsjj_posts.ID = mt2.post_id ) LEFT JOIN dxsjj_postmeta AS mt3 ON ( dxsjj_posts.ID = mt3.post_id ) LEFT JOIN dxsjj_postmeta AS mt4 ON ( dxsjj_posts.ID = mt4.post_id ) WHERE 1=1 AND ( ( dxsjj_postmeta.meta_key = 'factor_impacto' OR mt1.post_id IS NULL ) AND mt2.meta_key = 'autores' AND ( mt3.meta_key = 'id_grupos' AND mt3.meta_value LIKE '{e9a35ce74026bfbfa06cd439e251aa84283690e00980743db3b7056a3d9484d4}50006110{e9a35ce74026bfbfa06cd439e251aa84283690e00980743db3b7056a3d9484d4}' ) AND ( mt4.meta_key = 'anyo' AND CAST(mt4.meta_value AS SIGNED) >= '2019' ) ) AND dxsjj_posts.post_type = 'cnio_publication' AND ((dxsjj_posts.post_status = 'publish')) GROUP BY dxsjj_posts.ID ORDER BY CAST(mt4.meta_value AS SIGNED) DESC, CAST(dxsjj_postmeta.meta_value AS SIGNED) DESC, CAST(mt2.meta_value AS CHAR) ASC

  • de Melo-Martín I, Ortega-Paíno E. (2024). Biobanking Legislation in Spain: Advancing or Undermining Its Ethical Values?. Biopreservation & Biobanking 22, 242-247. CNIO Publication.
  • COVID-19 Host Genetics Initiative. (2023). A second update on mapping the human genetic architecture of COVID-19.. Nature 621, E7-E26. CNIO Publication.
  • Pairo-Castineira E, Rawlik K, Bretherick AD, Qi T, Wu Y, Nassiri I, McConkey GA, Zechner M, Klaric L, Griffiths F, Oosthuyzen W, Kousathanas A, Richmond A, Millar J, Russell CD, Malinauskas T, Thwaites R, Morrice K, Keating S, Maslove D, Nichol A, Semple MG, Knight J, Shankar-Hari M, Summers C, Hinds C, Horby P, Ling L, McAuley D, Montgomery H, Openshaw PJM, Begg C, Walsh T, Tenesa A, Flores C, Riancho JA, Rojas-Martinez A, Lapunzina P; GenOMICC Investigators; SCOURGE Consortium; ISARICC Investigators; 23andMe COVID-19 Team; Yang J, Ponting CP, Wilson JF, Vitart V, Abedalthagafi M, Luchessi AD, Parra EJ, Cruz R, Carracedo A, Fawkes A, Murphy L, Rowan K, Pereira AC, Law A, Fairfax B, Hendry SC, Baillie JK. (2023). GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.. Nature 671, 764-768. CNIO Publication.
  • Sanchez-Aguilera A, Masmudi-Martín M, Navas-Olive A, Baena P, Hernández-Oliver C, Priego N, Cordón-Barris L, Alvaro-Espinosa L, García S, Martínez S, Lafarga M; RENACER; Lin MZ, Al-Shahrour F, Menendez de la Prida L, Valiente M (2023). Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits. Cancer Cell 41, 1637-1649. CNIO Publication.
  • Castro-Santos P, Rojas-Martinez A, Riancho JA, Lapunzina P, Flores C, Carracedo Á, Díaz-Peña R; Scourge Cohort Group (2023). HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19. . HLA. 2023 Dec;102(6):731-739. doi: 10.1111/tan.15160. Epub 2023 Aug 1. PMID: 37528566. HLA 102, 731-739. CNIO Publication.
  • Valiente M, Ortega-Paino E (2023). Updating cancer research with patient-focused networks. Trends in Cancer (in press). CNIO Publication.
  • Zhu L, Retana D, García-Gómez P, Álvaro-Espinosa L, Priego N, Masmudi-Martín M, Yebra N, Miarka L, Hernández-Encinas E, Blanco-Aparicio C, Martínez S, Sobrino C, Ajenjo N, Artiga MJ, Ortega-Paino E, Torres-Ruiz R, Rodríguez-Perales S; RENACER, Soffietti R, Bertero L, Cassoni P, Weiss T, Muñoz J, Sepúlveda JM, González-León P, Jiménez-Roldán L, Moreno LM, Esteban O, Pérez-Núñez Á, Hernández-Laín A, Toldos O, Ruano Y, Alcázar L, Blasco G, Fernández-Alén J, Caleiras E, Lafarga M, Megías D, Graña-Castro O, Nör C, Taylor MD, Young LS, Varešlija D, Cosgrove N, Couch FJ, Cussó L, Desco M, Mouron S, Quintela-Fandino M, Weller M, Pastor J, Valiente M. (2022). A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis. EMBO Mol Med 14, 14552. CNIO Publication.